LAPORTE KATHLEEN 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
LAPORTE KATHLEEN
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-30+9,326→ 9,326 totalExercise: $0.45Exp: 2035-05-29→ Common Stock (9,326 underlying)
Footnotes (1)
- [F1]Represents the 1/3 time-based portion of an award of options to purchase 27,979 shares, vesting in equal monthly installments on the 4th of each month from July 4, 2025 through March 4, 2026, with the remaining portion subject to performance conditions.